Mark J. Fitzpatrick
Director/Board Member chez ALLENA PHARMACEUTICALS, INC.
Postes actifs de Mark J. Fitzpatrick
Sociétés | Poste | Début | Fin |
---|---|---|---|
ALLENA PHARMACEUTICALS, INC. | Director/Board Member | 06/04/2021 | - |
Independent Dir/Board Member | 06/04/2021 | - | |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Director/Board Member | 01/12/2021 | - |
Chief Executive Officer | 01/12/2021 | - |
Historique de carrière de Mark J. Fitzpatrick
Anciens postes connus de Mark J. Fitzpatrick
Sociétés | Poste | Début | Fin |
---|---|---|---|
CHIASMA, INC. | Director/Board Member | 01/10/2016 | 17/06/2019 |
Chief Executive Officer | 01/10/2016 | 17/06/2019 | |
Director of Finance/CFO | 17/06/2019 | 19/01/2021 | |
President | 01/10/2016 | 19/01/2021 | |
AEGERION PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/05/2011 | 01/06/2015 |
PROTARA THERAPEUTICS, INC. | Director of Finance/CFO | 01/07/2007 | 01/05/2011 |
Dynogen Pharmaceuticals, Inc.
Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | Director of Finance/CFO | 01/01/1998 | 13/11/2009 |
RenaMed Biologics, Inc.
RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services RenaMed Biologics, Inc. provided clinical cellular therapy. The company was founded by H. David Humes, James P. Sherblom and Richard A. Andrews in 1995 and was headquartered in Lincoln, RI. | Director of Finance/CFO | 01/08/2005 | - |
WorldStreet Corp.
WorldStreet Corp. Packaged SoftwareTechnology Services WorldStreet Corp. develops enterprise software applications. The American company was founded by Paul I. Walborsky. | Director of Finance/CFO | 01/01/1998 | 01/01/2002 |
Diacrin, Inc. (Delaware)
Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Diacrin, Inc. develops human cell transplant therapeutic products. The company is headquartered in Wilmington, DE. | Director of Finance/CFO | 01/01/1991 | 01/01/1998 |
░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formation de Mark J. Fitzpatrick
Boston College | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 11 |
Italie | 2 |
Suisse | 2 |
Opérationnelle
Director of Finance/CFO | 7 |
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Sectorielle
Health Technology | 9 |
Health Services | 2 |
Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
REPLIGEN CORPORATION | Health Technology |
ALLENA PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 9 |
---|---|
Diacrin, Inc. (Delaware)
Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Diacrin, Inc. develops human cell transplant therapeutic products. The company is headquartered in Wilmington, DE. | Health Technology |
Dynogen Pharmaceuticals, Inc.
Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | Health Technology |
Proteon Therapeutics, Inc.
Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA. | Health Technology |
Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Chiasma, Inc.
Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Chiasma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of oral forms of therapies that are available by injection. Its products include octreotide capsules. The company was founded by Shmuel A. Ben-Sasson and Guy Yachin in 2001 and is headquartered in Needham, MA. | Health Technology |
RenaMed Biologics, Inc.
RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services RenaMed Biologics, Inc. provided clinical cellular therapy. The company was founded by H. David Humes, James P. Sherblom and Richard A. Andrews in 1995 and was headquartered in Lincoln, RI. | Health Services |
WorldStreet Corp.
WorldStreet Corp. Packaged SoftwareTechnology Services WorldStreet Corp. develops enterprise software applications. The American company was founded by Paul I. Walborsky. | Technology Services |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Commercial Services |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Health Technology |
- Bourse
- Insiders
- Mark J. Fitzpatrick
- Expérience